Galectin-9/CD44介导的滋养细胞-蜕膜巨噬细胞异常对话诱导胎盘血管重塑不良致子痫前期的分子机制
批准号:
31970859
项目类别:
面上项目
资助金额:
59.0 万元
负责人:
杜美蓉
依托单位:
学科分类:
生殖免疫与移植免疫
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
杜美蓉
中文摘要
滋养细胞侵袭力下降、子宫螺旋动脉重塑不良是子痫前期(PE)特征性病理改变与重要病因,但其确切机制不清。我们发现PE患者胎盘滋养细胞(TROs)与外周血分泌高水平Galectin-9(Gal-9),募集与活化蜕膜巨噬细胞(M¢),并以CD44依赖性诱导其促炎表型、抑制其产生IL-8与内皮细胞管腔形成;孕早/中期应用Gal-9诱导孕鼠PE样改变,伴胎盘发育不良与子宫局部M¢异常变化,提示Gal-9/CD44介导的TROs与蜕膜M¢互作异常诱导了胎盘血管重塑障碍,致PE发生。拟探讨PE患者Gal-9上调原因;解析其对蜕膜M¢募集与训导机制及其抑制M¢产生IL-8的潜在原因,并建立TROs、血管内皮细胞与蜕膜M¢共培养体系模拟体外血管重塑模型以及构建CD44在M¢敲除鼠与PE模型解析Gal-9/CD44信号对体外胎盘血管重塑、体内胎盘发育与妊娠结局的影响及其机制,为PE早期预测与防治提供新思路。
英文摘要
The decreased trophoblast invasiveness and repaired uterine spiral artery remodeling are characteristic pathological changes and important etiology of preeclampsia (PE), but the underlying mechanism is still uncertain. Our previous studies found that trophoblasts (TROs) and peripheral blood of PE patients secreted high levels of galectin-9 (Gal-9), which recruited and activated decidual macrophages (M¢). Gal-9 induced the decidual M¢ into a proinflammatory phenotype, and inhibited their IL-8 production and endothelial cell lumen formation in a CD44-dependent manner. Exogenous Gal-9 treatment during the first/second trimester of pregnancy induced preeclampsia-like changes, accompanied with placental dysplasia and abnormal uterine M¢ alternations, indicating that aberrant interaction between TROs and decidual M¢ mediated by Gal-9/CD44 induced placental vascular remodeling disorder and finally resulted in preeclampsia. In this study, we will investigate the causes of Gal-9 up-regulation in PE patients, and analyze the mechanism of its effects on decidual M¢ recruitment and education, as well as the potential reasons for its suppression on IL-8 production by decidual M¢. We will establish the co-culture system of TROs, vascular endothelial cells and decidual M¢ to simulate the vascular remodeling model in vitro, and constructed mice model of conditioned-knockout of CD44 on macrophages and PE mice model to investigate the effect and mechanism of Gal-9/CD44 signal on in-vitro placental vascular remodeling, in-vivo placental development and pregnancy outcomes, providing new ideas for early prediction and prevention of PE.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Involvement of the Tim-3 Pathway in the Pathogenesis of Pre-Eclampsia
Tim-3 通路参与先兆子痫的发病机制
DOI:
10.1007/s43032-021-00675-3
发表时间:
2021-07
期刊:
Reproductive Sciences
影响因子:
2.9
作者:
[Wang Songcun, Chen Chunqin, Sun Fengrun, Li Mengdie, Du Meirong, Li Xiaotian, Zhang Ying]
通讯作者:
Zhang Ying
DOI:
10.1016/j.mce.2023.111946
发表时间:
2023-05-04
期刊:
MOLECULAR AND CELLULAR ENDOCRINOLOGY
影响因子:
4.1
作者:
[Zhao,Weijie, Xu,Chunfang, Du,Meirong]
通讯作者:
Du,Meirong
DOI:
10.7150/ijbs.68224
发表时间:
2022
期刊:
International journal of biological sciences
影响因子:
9.2
作者:
[Li YY, Lin YK, Li Y, Liu XH, Li DJ, Wang XL, Wang L, Zhu YZ, Yu M, Du MR]
通讯作者:
Du MR
Mesenchymal stem cells enhance Treg immunosuppressive function at the fetal-maternal interface.
间充质干细胞增强母胎界面的 Treg 免疫抑制功能。
DOI:
10.1016/j.jri.2021.103366
发表时间:
2021
期刊:
Journal of reproductive immunology
影响因子:
3.4
作者:
[Di, Yi, Yun, Dongmei Zhao, Meirong Du]
通讯作者:
Meirong Du
Galectin-9 regulates HTR8/SVneo function via JNK signaling
Galectin-9 通过 JNK 信号传导调节 HTR8/SVneo 功能。
DOI:
10.1530/rep-19-0543
发表时间:
2021
期刊:
Reproduction
影响因子:
3.8
作者:
[Li Mengdie, Peng Xi, ong, Qian Jinfeng, Sun Fengrun, Chen Chunqin, Wang Songcun, Zhang Jianping, Du Meirong]
通讯作者:
Du Meirong
共 37 条
蜕膜基质细胞铁死亡信号异常致早期妊娠失败的分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:杜美蓉
-
依托单位:
胎盘发育不良与蜕膜化障碍致早期妊娠失败的分子机制及其干预研究
-
批准号:81630036
-
项目类别:重点项目
-
资助金额:275.0万元
-
批准年份:2016
-
负责人:杜美蓉
-
依托单位:
蜕膜CXCR4+与CXCR4-NK细胞在CD4+T细胞亚群平衡与母-胎免疫耐受中的调节作用
-
批准号:31570920
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2015
-
负责人:杜美蓉
-
依托单位:
胚胎滋养细胞诱导母-胎免疫耐受维持正常妊娠的分子机制
-
批准号:91542116
-
项目类别:重大研究计划
-
资助金额:70.0万元
-
批准年份:2015
-
负责人:杜美蓉
-
依托单位:
Galectin9/Tim3相互作用调节蜕膜CD4+T细胞分化与功能的分子机制
-
批准号:81370770
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2013
-
负责人:杜美蓉
-
依托单位:
人早孕母-胎界面CXCL12/CXCR4介导蜕膜NK细胞功能性发育的分子机制
-
批准号:31171437
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:杜美蓉
-
依托单位:
环孢素A诱导母-胎界面Th2型免疫优势的分子机制
-
批准号:81070537
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2010
-
负责人:杜美蓉
-
依托单位:
国内基金
海外基金